Skip to search formSkip to main contentSkip to account menu

LFG-316

Known as: LFG316 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Tesidolumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Generation and Characterization of LFG316, A Fully-Human Anti-C5 Antibody for the Treatment of Age-Related Macular Degeneration
2014
2014
A Phase I single ascending dose study of an intravitreal (IVT) anti-C5 monoclonal antibody (LFG316) in patients with advanced age related macular degeneration (AMD)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)